Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 13, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Sarcopenia
Interventions
DRUG

cetylpyridinium chloride

Four study groups take cetylpyridinium chloride of 1.5mg, 3mg, 4.5mg and 6mg daily for two weeks.

DRUG

Placebo

Control group takes the placebo for the same period.

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02297997 - Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy | Biotech Hunter | Biotech Hunter